In a welcome move, Globe Life saw its Relative Strength Rating improve from 66 to 72 on Thursday.
IBD's unique RS Rating tracks market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
History reveals that the best-performing stocks tend to have an 80 or better RS Rating in the early stages of their moves. See if Globe Life can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Globe Life is working on a double bottom with a 113.16 buy point. See if it can break out in heavy trade.
Earnings growth picked up last quarter from 14% to 29%. But revenue gains fell from 9% to 5%. Keep an eye out for the company's next round of numbers on or around Jan. 29.
The company holds the No. 2 rank among its peers in the Insurance-Life industry group. Primerica is the top-ranked stock within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
